Influenza A And Influenza B Multiplex Nucleic Acid Assay
OZE is the FDA product code for Influenza A And Influenza B Multiplex Nucleic Acid Assay, a class II device type, regulated under 21 CFR 866.3980. FDA's definition for this code reads: "An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms...". As of , FDA records hold 20 510(k) clearances under this code, the most recent dated , and 5 recalls.
Classification record
- Product code
- OZE
- Device name
- Influenza A And Influenza B Multiplex Nucleic Acid Assay
- FDA definition
- An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of influenza A and B nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract influenza viral infections if used in conjunction with other clinical and laboratory findings.
- Regulation
- 21 CFR 866.3980
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 20
- Ingested recalls
- 5
Clearances, product code OZE
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Applicants with the most clearances
Product code OZE| Applicant | Clearances |
|---|---|
| Centers for Disease Control and Prevention | 9 |
| Centers for Disease Control and Prevention (CDC) | 3 |
| Ortho-Clinical Diagnostics, Inc. | 3 |
| Abbott Diagnostics Scarborough, Inc. | 1 |
| Alere Scarborough, Inc. | 1 |
| Center for Disease Control and Prevention (Cdc) | 1 |
| Indevr, Inc. | 1 |
| Mesa Biotech, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Diagnostics Scarborough, Inc.
- ACRO BIOTECH Inc.
- Applied BioCode, Inc.
- Autonomous Medical Devices Incorporated
- BioFire Defense, LLC
- BioFire Diagnostics, LLC
- Centers for Disease Control and Prevention
- Diversified Synergies, LLC
- Enercon Technologies
- Genmark Diagnostics, Inc.
- Hochuen Medical Sdn. Bhd.
- Hochuen Medical Technology Co.,Ltd.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
